Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $74.41 USD
Change Today -1.03 / -1.37%
Volume 525.4K
DVA On Other Exchanges
New York
As of 2:37 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by DAVITA HEALTHCARE PARTNERS I (DVA) in the last 6 months

Announced 08/24/15
415.00M for Renal Ventures Management, LLC

DaVita HealthCare Partners Inc. (NYSE:DVA) entered into an agreement to acquire Renal Ventures Management, LLC for approximately $420 million in cash on August 24, 2015. The transaction also includes acquisition of a 100% interest in all dialysis centers owned by Renal Ventures. Credit Suisse acted as financial advisor, Morrison & Foerster, LLP and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. acted as legal advisors to DaVita. Raymond James & Associates, Inc. ...
Read More

DVA's price was unchanged after the transaction was announced on 08/24/15.
Investor / Buyer
DaVita HealthCare Partners Inc.
Financial Advisor
Raymond James & Associates, Inc.
Legal Advisor
Brownstein Hyatt Farber Schreck, LLP
Announced 04/14/15
726.00M for DaVita HealthCare Partners Inc.

DaVita HealthCare Partners Inc. (NYSE:DVA) announces a share repurchase program. Under the program, the company will repurchase up to $725.94 million worth of its share. Repurchases under the program will be made in the open market or privately negotiated transactions, including without limitation, accelerated share repurchase transactions, derivative transactions, and under Rule 10b5-1 plans. There can be no assurance as to the precise number of shares that will be ...
Read More

DVA's price was unchanged after the transaction was announced on 04/14/15.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DVA:US $74.43 USD -1.01

DVA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Apollo Medical Holdings Inc $7.50 USD 0.00
Fresenius Medical Care AG & Co KGaA €67.78 EUR -1.14
Fresenius SE & Co KGaA €62.40 EUR -0.88
IPC Healthcare Inc $79.10 USD -0.10
Team Health Holdings Inc $57.04 USD -1.05
View Industry Companies

Industry Analysis


Industry Average

Valuation DVA Industry Range
Price/Earnings 36.2x
Price/Sales 1.2x
Price/Book 3.1x
Price/Cash Flow 15.2x
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAVITA HEALTHCARE PARTNERS I, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at